ストックスクリーナーアプリを入手
2.76
11.25%
-0.35
アフターアワーズ：
2.76
前日終値:
$3.11
開ける：
$2.96
24時間の取引高:
108.07K
Relative Volume:
1.19
時価総額：
$105.74M
収益：
$2.76M
当期純損益:
$-49.12M
株価収益率:
-1.84
EPS:
-1.5
ネットキャッシュフロー:
$-46.21M
1週間 パフォーマンス:
-37.27%
1か月 パフォーマンス:
-34.44%
6か月 パフォーマンス:
-44.58%
1年 パフォーマンス:
-44.47%
1日の値動き範囲:
$2.65
$3.22
1週間の範囲:
$2.65
$4.63
52週間の値動き範囲:
$2.65
$8.8699
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
名前
Orchestra Biomed Holdings Inc
セクター
電話
646-343-9298
住所
150 UNION SQUARE DRIVE, NEW HOPE
OBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
2.76 | 105.74M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-20 | 開始されました | BTIG Research | Buy |
| 2025-01-02 | 開始されました | Barclays | Overweight |
| 2024-08-22 | 開始されました | H.C. Wainwright | Buy |
| 2024-07-25 | 開始されました | B. Riley Securities | Buy |
| 2024-01-19 | 開始されました | Jefferies | Buy |
| 2023-02-24 | 開始されました | Piper Sandler | Overweight |
| 2023-02-07 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Orchestra Biomed Holdings Inc (OBIO) 最新ニュース
Where Orchestra BioMed Hldgs Stands With Analysts - Benzinga
H.C. Wainwright cuts Orchestra BioMed stock target to $12 By Investing.com - Investing.com UK
Health Check: How Prudently Does Orchestra BioMed Holdings (NASDAQ:OBIO) Use Debt? - simplywall.st
HighTower Advisors LLC Has $274,000 Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra BioMed (NASDAQ:OBIO) Earns Buy Rating from Chardan Capital - Defense World
Orchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular Therapy - MyChesCo
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates - MSN
Orchestra BioMed (NASDAQ:OBIO) Posts Earnings Results, Hits Estimates - MarketBeat
BTIG maintains $12 target on Orchestra BioMed stock By Investing.com - Investing.com Canada
OBIO stock touches 52-week low at $3.63 amid market challenges By Investing.com - Investing.com South Africa
OBIO stock touches 52-week low at $3.63 amid market challenges - Investing.com Australia
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update - The Manila Times
(OBIO) Trading Advice - news.stocktradersdaily.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Freightos And 2 Other Penny Stocks Worth Watching - simplywall.st
Orchestra BioMed (NASDAQ:OBIO) Research Coverage Started at BTIG Research - ETF Daily News
Orchestra BioMed (NASDAQ:OBIO) Coverage Initiated at BTIG Research - Defense World
BTIG Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - Nasdaq
BTIG sets Orchestra BioMed stock with $12 target By Investing.com - Investing.com Australia
Insiders In Orchestra BioMed Holdings Left Out From 10% Price Rise After Disposing Stock - simplywall.st
BTIG Initiates Orchestra BioMed at Buy With $12 Price Target -March 20, 2025 at 07:15 am EDT - Marketscreener.com
Orchestra BioMed (OBIO) Projected to Post Earnings on Wednesday - Defense World
Orchestra BioMed (NASDAQ:OBIO) Given Buy Rating at HC Wainwright - Defense World
H.C. Wainwright maintains $14 target on Orchestra BioMed stock By Investing.com - Investing.com South Africa
Promising Clinical Developments and Strategic Advancements Drive Buy Rating for Orchestra BioMed Holdings - TipRanks
Dr. Vivek Reddy Joins Orchestra BioMed to Lead Breakthrough Hypertension Study - MSN
Orchestra BioMed Highlights Strategic Initiatives and Innovations - TipRanks
Orchestra BioMed to Participate in Upcoming Investor Conferences - MSN
Orchestra BioMed Updates Executive Compensation Policies - TipRanks
Orchestra BioMed Welcomes Christopher Cleary to Board of Directors - MSN
Orchestra BioMed to Present at Upcoming Investor Conferences - GlobeNewswire
3 Major Healthcare Conferences Where Orchestra BioMed Will Share Its Growth Story - StockTitan
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive - GlobeNewswire
Mount Sinai's Top Cardiac Expert Takes Helm of Groundbreaking Hypertension Treatment Study - StockTitan
Orchestra BioMed (NASDAQ:OBIO) Shares Up 5.1%Time to Buy? - MarketBeat
Orchestra BioMed Unveils Groundbreaking Data on AVIM Therapy’s Potential to Prevent Heart Failure - MSN
SG Americas Securities LLC Has $51,000 Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra BioMed (NASDAQ:OBIO) Trading 5.1% Higher – Here’s Why - Defense World
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Sees Large Decline in Short Interest - Defense World
How the (OBIO) price action is used to our Advantage - Stock Traders Daily
Individual investors among Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest stockholders and were hit after last week's 11% price drop - Simply Wall St
Orchestra BioMed Says AVIM Therapy Improves Echo Markers of Diastolic Dysfunction - Marketscreener.com
Orchestra BioMed Announces Data Demonstrating Favorable - GlobeNewswire
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference - GlobeNewswire
Clinical Data: Orchestra BioMed's AVIM Therapy Shows Significant Heart Failure Prevention Benefits | OBIO Stock News - StockTitan
Orchestra Biomed Holdings Inc (OBIO) 財務データ
収益
当期純利益
現金流量
EPS
3.01%
大文字化:
|
ボリューム (24 時間):